levodopa has been researched along with ADDH in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (63.16) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Grimm, O; Kranz, TM; Reif, A; Thomä, L | 1 |
| Bruni, O; Ferri, R; Novelli, L; Picchietti, DL; Picchietti, MA | 1 |
| Brown, JA; Conyers, SB; Emnett, RJ; Gutmann, DH; O'Malley, KL; White, CR; Wozniak, DF; Yuede, CM | 1 |
| Cohen, B; Couvadelli, BV; England, SJ; Fisher, BC; Hening, WA; Lewin, D; Picchietti, DL; Siddiqui, F; Wagner, ML; Walters, AS; Winnie, G | 1 |
| Nieoullon, A | 1 |
| Buitelaar, JK; Kemner, C; Kenemans, JL; Koelega, HS; Maes, RA; Overtoom, CC; van der Gugten, J; van der Molen, MW; van Engeland, H; Verbaten, MN; Westenberg, H | 1 |
| Amalric, M; Baunez, C; Chezaubernard, C; Maurin, B; Morain, P; Nieoullon, A; Puma, C; Turle-Lorenzo, N | 1 |
| Dement'eva, NF; Ermolina, LA; Ezhkova, VA; Mozhaeva, EG | 1 |
| Reimherr, F; Wender, PH; Wood, D | 1 |
| Reimherr, FW; Wender, PH; Wood, DR | 1 |
| Brown, GL; Bunney, WE; Ebert, MH; Langer, DH; Rapoport, JL | 2 |
| Karniol, IG; Knobel, M; Strauss, L | 1 |
| Moskowitz, MA; Wurtman, RJ | 1 |
| Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
| Reimherr, FW; Ward, M; Wender, PH; Wood, DR | 1 |
| Garfinkel, BD; Jensen, JB | 1 |
| Widhalm, S | 1 |
| McConnell, H | 1 |
3 review(s) available for levodopa and ADDH
| Article | Year |
|---|---|
Dopamine and the regulation of cognition and attention.
Topics: Adult; Aged; Aging; Animals; Antiparkinson Agents; Attention; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Basal Ganglia; Child; Cognition; Cognition Disorders; Dopamine; Dopamine Agonists; Humans; Levodopa; Limbic System; Middle Aged; Models, Neurological; Models, Psychological; Parkinson Disease; Phylogeny; Receptors, Dopamine; Schizophrenic Psychology | 2002 |
[Therapy and social adaptation of patients with mental retardation (a review of the literature)].
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebral Palsy; Child; Child, Preschool; Down Syndrome; Education of Intellectually Disabled; Humans; Infant; Intellectual Disability; Levodopa; Male; Phenylketonurias; Rehabilitation, Vocational; Social Adjustment | 1981 |
Catecholamines and neurologic diseases (second of two parts).
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cerebrovascular Disorders; Dopamine; Dysautonomia, Familial; Dystonia Musculorum Deformans; Hepatic Encephalopathy; Homovanillic Acid; Humans; Huntington Disease; Levodopa; Movement Disorders; Multiple Sclerosis; Nervous System Diseases; Parkinson Disease; Phenylketonurias; Seizures; Spinal Cord Injuries; Torticollis; Tourette Syndrome | 1975 |
7 trial(s) available for levodopa and ADDH
| Article | Year |
|---|---|
Time structure of leg movement activity during sleep in attention-deficit/hyperactivity disorder and effects of levodopa.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dopamine Agents; Electroencephalography; Female; Humans; Levodopa; Male; Nocturnal Myoclonus Syndrome; Polysomnography; Restless Legs Syndrome; Sleep; Treatment Outcome | 2013 |
L-Dopa improves Restless Legs Syndrome and periodic limb movements in sleep but not Attention-Deficit-Hyperactivity Disorder in a double-blind trial in children.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dopamine Agents; Double-Blind Method; Female; Humans; Levodopa; Male; Neuropsychological Tests; Nocturnal Myoclonus Syndrome; Placebo Effect; Polysomnography; Restless Legs Syndrome; Sleep; Treatment Outcome | 2011 |
Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder.
Topics: Attention; Attention Deficit Disorder with Hyperactivity; Child; Choice Behavior; Desipramine; Dopamine Agents; Double-Blind Method; Enzyme Inhibitors; Humans; Hydroxyindoleacetic Acid; Inhibition, Psychological; Levodopa; Male; Methylphenidate; Prolactin; Reaction Time | 2003 |
An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Carbidopa; Clinical Trials as Topic; Drug Combinations; Drug Evaluation; Drug Synergism; Female; Humans; Levodopa; Male; Methylphenidate | 1980 |
Questioning a dopaminergic hypothesis.
Topics: Attention Deficit Disorder with Hyperactivity; Carbidopa; Clinical Trials as Topic; Dopamine; Humans; Levodopa | 1981 |
Behavioral effects of carbidopa/levodopa in hyperactive boys.
Topics: Attention Deficit Disorder with Hyperactivity; Carbidopa; Child; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male | 1982 |
An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Female; Humans; Levodopa; Male; Middle Aged; Phenylalanine; Psychiatric Status Rating Scales; Tyrosine | 1987 |
9 other study(ies) available for levodopa and ADDH
| Article | Year |
|---|---|
Is genetic risk of ADHD mediated via dopaminergic mechanism? A study of functional connectivity in ADHD and pharmacologically challenged healthy volunteers with a genetic risk profile.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Brain; Brain Mapping; Dopamine; Healthy Volunteers; Humans; Levodopa; Magnetic Resonance Imaging; Neural Pathways; Risk Factors | 2022 |
Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
Topics: Animals; Attention; Attention Deficit Disorder with Hyperactivity; Brain; Child; Corpus Striatum; Dopamine; Genes, Neurofibromatosis 1; Humans; Levodopa; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mice, Transgenic; Motor Activity; Neurofibromatosis 1; Neurofibromin 1; Neurons; Optic Nerve Glioma; Substantia Nigra | 2010 |
The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Attention Deficit Disorder with Hyperactivity; Cognition; Corpus Striatum; Dopamine Agonists; Drug Therapy, Combination; Levodopa; Male; Mazindol; Motor Activity; Parkinson Disease; Piribedil; Rats; Rats, Wistar; Reaction Time | 2006 |
Effects of levodopa on attention deficit disorder, residual type.
Topics: Adult; Attention; Attention Deficit Disorder with Hyperactivity; Carbidopa; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male | 1982 |
L-dopa and treatment of hyperactive children.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Dose-Response Relationship, Drug; Humans; Levodopa; Male | 1981 |
Methylphenidate-induced chorea: case report and pharmacologic implications.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Child; Child, Preschool; Chorea; Dopamine; Dyskinesia, Drug-Induced; Guinea Pigs; Humans; Hyperkinesis; Levodopa; Male; Methylphenidate; Stereotyped Behavior | 1978 |
Neuroendocrine aspects of attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Growth Hormone; Humans; Levodopa; Male | 1988 |
[Current status of conservative therapy of extrapyramidal movement disorders in childhood and adolescence].
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autogenic Training; Basal Ganglia; Basal Ganglia Diseases; Brain Damage, Chronic; Child; Child, Preschool; Education, Special; Electroencephalography; Female; Follow-Up Studies; Humans; Levodopa; Male; Muscle Hypertonia; Parkinson Disease, Secondary; Psychotropic Drugs; Risk; Tic Disorders | 1985 |
Catecholamine metabolism in the attention deficit disorder: implications for the use of amino acid precursor therapy.
Topics: Attention Deficit Disorder with Hyperactivity; Catecholamines; Dopamine; Humans; Levodopa; Methylphenidate; Norepinephrine; Pemoline; Tyrosine | 1985 |